Published in Medical Letter on the CDC and FDA, April 11th, 2000
The Triage BNP Test is designed to provide physicians with rapid, quantifiable measurements of B-type natriuretic protein (BNP), a protein marker for congestive heart failure (CHF). In voting, the Advisory Panel indicated that it did not accept the company's application of clinical trial data supporting the proposed product claim that the Triage BNP Test could be an aid for the diagnosis of CHF at the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA